Collegium Pharmaceutical (COLL) Other Accumulated Expenses (2014 - 2025)
Collegium Pharmaceutical (COLL) posted quarterly Other Accumulated Expenses of $6.4 million for Q3 2025, down 11.27% year-over-year from $7.2 million in Q3 2024, and up 48.22% quarter-over-quarter from $4.3 million in Q2 2025.
Collegium Pharmaceutical (COLL) Other Accumulated Expenses (2014 - 2025) Analysis & Trends
Collegium Pharmaceutical's Other Accumulated Expenses history runs 12 years deep, the most recent figure standing at $6.4 million for Q3 2025.
- In Q3 2025, Other Accumulated Expenses fell 11.27% year-over-year to $6.4 million; the TTM figure through Sep 2025 stood at $6.4 million (down 11.27% YoY), while the FY2024 annual figure was $13.1 million, up 264.44% from the prior year.
- Other Accumulated Expenses for Q3 2025 stood at $6.4 million, up from $4.3 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $14.3 million in Q2 2021, with the low at $1.0 million in Q3 2021.
- The 5-year median for Other Accumulated Expenses is $7.0 million (2022), against an average of $7.0 million.
- The sharpest annual moves came in 2021 and 2022: Other Accumulated Expenses jumped 1341.29% in 2021, then tumbled 78.44% in 2022.
- Collegium Pharmaceutical's Other Accumulated Expenses stood at $9.9 million in 2021, then slumped by 65.28% to $3.4 million in 2022, then gained by 4.41% to $3.6 million in 2023, then soared by 264.44% to $13.1 million in 2024, then sank by 51.41% to $6.4 million in 2025.
- Business Quant data shows COLL's Other Accumulated Expenses at $6.4 million in Q3 2025, $4.3 million in Q2 2025, and $4.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Collegium Pharmaceutical | 897.87 Mn | 748.55 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6.38 Mn |
| Jun 30, 2025 | 4.30 Mn |
| Mar 31, 2025 | 4.83 Mn |
| Dec 31, 2024 | 13.12 Mn |
| Sep 30, 2024 | 7.19 Mn |
| Jun 30, 2024 | 13.45 Mn |
| Mar 31, 2024 | 2.09 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Sep 30, 2023 | 2.47 Mn |
| Jun 30, 2023 | 14.29 Mn |
| Mar 31, 2023 | 7.73 Mn |
| Dec 31, 2022 | 3.45 Mn |
| Sep 30, 2022 | 6.97 Mn |
| Jun 30, 2022 | 3.09 Mn |
| Mar 31, 2022 | 7.91 Mn |
| Dec 31, 2021 | 9.93 Mn |
| Sep 30, 2021 | 1.05 Mn |
| Jun 30, 2021 | 14.31 Mn |
| Mar 31, 2021 | 7.32 Mn |
| Dec 31, 2020 | 884,000.00 |